Advertisement
Advertisement
U.S. Markets close in 1 hr 43 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cardiol Therapeutics Inc. (CRDL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9000+0.1000 (+5.56%)
As of 02:17PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8000
Open1.8000
Bid1.9100 x 1300
Ask1.9200 x 900
Day's Range1.7400 - 1.9399
52 Week Range1.5500 - 4.9600
Volume143,641
Avg. Volume709,317
Market Cap112.664M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-0.7290
Earnings DateAug 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.16
  • Newsfile

    Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board

    Oakville, Ontario--(Newsfile Corp. - January 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease, today announced the appointment of Paul M. Ridker, MD, MPH, Bruce McManus, PhD, MD, and Joseph A. Hill, MD, PhD, to its Scientific Advisory Board (SAB). "We are pleased to welcome distinguished th

  • Newsfile

    Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

    Oakville, Ontario--(Newsfile Corp. - November 5, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing anti-inflammatory therapies for the treatment of cardiovascular disease, announced today the closing of its previously announced public offering (the "Offering") of 16,350,000 units of the Company (the "Units") at a price to the public of US$3.07 per Unit for gross proceeds of US$50,194,500, before

  • Simply Wall St.

    What You Need To Know About Cardiol Therapeutics Inc.'s (TSE:CRDL) Investor Composition

    The big shareholder groups in Cardiol Therapeutics Inc. ( TSE:CRDL ) have power over the company. Large companies...

Advertisement
Advertisement